175442-56-5

Upstream product

• 6373-46-2 p-benzyloxyaniline 

Downstream Products

• 175442-66-7 (S)-2-{[4-Benzyloxy-2-(2-tert-butoxycarbonylsulfanyl-ethylsulfanyl)-phenylcarbamoyl]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 175442-65-6 (S)-2-{[2-(2-tert-Butoxycarbonylsulfanyl-ethylsulfanyl)-4-(tert-butyl-dimethyl-silanyloxy)-phenylcarbamoyl]-methyl}-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 175442-59-8 Thiocarbonic acid S-{2-[5-benzyloxy-2-(2,2,2-trifluoro-acetylamino)-phenylsulfanyl]-ethyl} ester O-tert-butyl ester 
• 175442-58-7 Thiocarbonic acid S-[2-(2-amino-5-benzyloxy-phenylsulfanyl)-ethyl] ester O-tert-butyl ester 
• 175442-63-4 Thiocarbonic acid S-{2-[2-amino-5-(tert-butyl-dimethyl-silanyloxy)-phenylsulfanyl]-ethyl} ester O-tert-butyl ester 
• 175442-60-1 2,2,2-Trifluoro-N-[4-hydroxy-2-(2-mercapto-ethylsulfanyl)-phenyl]-acetamide 
• 175442-62-3 2-[2-Amino-5-(tert-butyl-dimethyl-silanyloxy)-phenylsulfanyl]-ethanethiol 
• 175442-61-2 4-Amino-3-(2-mercapto-ethylsulfanyl)-phenol 
• 100493-31-0 2-Amino-5-benzyloxy-benzenethiol 

Relevant academic research and scientific papers

Heterocyclic antiviral compounds

Compounds having the formula I wherein A, m and R1 are herein defined are Hepatitis C virus polymerase inhibitors. Also disclosed are compositions and methods for treating diseases mediated by HCV and for inhibiting hepatitis replication. Also disclosed are processes for making the compounds and synthetic intermediates used in the process

Synthesis of tetradentate bisamino-bisthiol complexes of oxorhenium(V) as structural mimics of steroids

Two tetradentate chelate systems have been synthesized in order to prepare metal complexes with oxorhenium(V) whose structures will mimic that of steroids. The chelate system with amide/amine/thioether/thiol donor sites failed to give a stable complex, bu